As the flagship event for the pharmaceutical industry in Southeast Asia, CPhI South East Asia 2024 was held from July 10th to 12th at the IMPACT Exhibition Center in Bangkok, Thailand. Shanghai JSD New Medical Material Co., Ltd (hereinafter referred to as “JSD”), specializing in high-end medical packaging solutions, made a stunning appearance at the exhibition, showcasing its core technology product—an innovative co-injection cap for blow-fill-seal (BFS) infusion bottles—demonstrating China’s innovative strength and superior quality to the rapidly growing East and West Asian market.
With the booming development of the Southeast Asian pharmaceutical market and the continuous upgrading of pharmaceutical technology, the demand for efficient and safe aseptic injectable packaging is becoming increasingly urgent. As the gold standard for aseptic formulation production, the performance of its core packaging component—the co-injection cap—is crucial. The co-injection caps presented by JSD New Medical Material Co., with their unique multi-layer co-injection molding process, successfully solve multiple challenges of BFS packaging in terms of seal integrity, drug compatibility, and ease of clinical use, becoming a highlight of the formulation packaging field at the exhibition.
At the JSD’s booth, professional visitors and customers gained a comprehensive understanding of the superior features of this co-injection cap through detailed sample displays, technical documents, and in-depth explanations from engineers.
• Ultimate sealing, protecting the sterile barrier of medicines: The carefully designed structure and material combination ensures that the cap and bottle mouth form an impeccable seal after high-temperature fusion, effectively blocking the penetration of microorganisms and gases, and providing sterile protection for medicines from production to use.
• Excellent compatibility ensures drug stability: The inner layer material in contact with the drug solution is strictly selected, with extremely low exudates and adsorption, fully meeting the stringent packaging requirements of various sensitive drugs (such as nutrient solutions, antibiotics, etc.), ensuring the efficacy and safety of the drugs.
• Human-centered design enhances clinical efficiency: The lid features an easily identifiable opening position and a smooth break ring, allowing medical staff to open it easily and safely, greatly improving the efficiency of clinical dispensing and effectively avoiding accidental risks caused by improper opening.
• Stable compatibility and optimized production line efficiency: The product has precise dimensional tolerances and excellent mechanical properties, which can be perfectly adapted to the mainstream high-speed BFS filling lines in the international market, ensuring a smooth and stable production process and helping customers improve overall production efficiency.
During the exhibition, JSD’s booth attracted a large number of R&D, procurement, and production management personnel from pharmaceutical companies in Thailand, Vietnam, Indonesia, Malaysia, and other countries. They showed great interest in the co-fill cap designed specifically for BFS technology and held several fruitful discussions with the JSD team on topics such as technical parameters, customization possibilities, and localized service support, laying a solid foundation for further in-depth cooperation.
The exhibition representative from Shanghai JSD New Medical Material Co., Ltd stated, “CPhI South East Asia is a key part of our global strategy. The Southeast Asian market is dynamic and highly receptive to innovative pharmaceutical technologies. Our BFS co-injection caps, which we are showcasing today, are designed to meet the region’s growing demand for high-end aseptic packaging. Positive customer feedback has given us tremendous confidence. We will continue to uphold our ‘innovation-driven, quality-first’ philosophy, and dedicate ourselves to providing safer and more reliable medical packaging solutions for our global pharmaceutical partners.”
The success of this trip to Bangkok has further consolidated the brand influence of Shanghai JSD New Medical Material Co., Ltd in the Southeast Asian market, marking another solid step forward for the company in deepening its international layout and serving the global pharmaceutical industry.
